Clinical Trial Update: Efficacy & Safety of Infliximab Monotherapy Vs Combination Therapy Vs AZA Monotherapy in Ulcerative Colitis (Part 1) Maintenance Vs Intermittent Therapy for Maintaining Remission (Part 2)(Study P04807) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing infliximab monotherapy, infliximab plus azathioprine, and azathioprine monotherapy for maintaining remission in ulcerative colitis was…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Azathioprine (azathioprine)
• Infliximab (infliximab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Ulcerative Colitis | Phase 3 | Status: TERMINATED | Results posted: 2011-12-16